{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:13:06Z","timestamp":1761581586288,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.clbc.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T21:46:00Z","timestamp":1500587160000},"page":"128-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype"],"prefix":"10.1016","volume":"18","author":[{"given":"Maki","family":"Namura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koyu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideko","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2017.07.001_bib1","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/cncr.23083","article-title":"Preoperative chemotherapy treatment of breast cancer\u2014a review","volume":"110","author":"Buzdar","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2017.07.001_bib2","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1200\/JCO.2005.02.6187","article-title":"Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update","volume":"24","author":"Kaufmann","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2017.07.001_bib3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00330-004-2246-z","article-title":"Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy","volume":"14","author":"Londero","year":"2004","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clbc.2017.07.001_bib4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2214\/ajr.179.5.1791193","article-title":"Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy","volume":"179","author":"Partridge","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clbc.2017.07.001_bib5","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2214\/AJR.09.3568","article-title":"Breast cancers not detected at MRI: review of false-negative lesions","volume":"194","author":"Shimauchi","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clbc.2017.07.001_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2007.02.020","article-title":"Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study","volume":"69","author":"Bollet","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2017.07.001_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejrad.2006.07.014","article-title":"Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients","volume":"60","author":"Nagashima","year":"2006","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clbc.2017.07.001_bib8","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1016\/j.ejca.2012.05.023","article-title":"Meta-analysis of the association of breast cancer subtype and pathologic complete response to neaodjuvant chemotherapy","volume":"48","author":"Houssami","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2017.07.001_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10549-007-9744-z","article-title":"Phase II study of preoperative sequential FEC and docetaxel predicts pathological response and disease free survival","volume":"110","author":"Toi","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.07.001_bib10","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1200\/JCO.2006.08.2271","article-title":"Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome","volume":"25","author":"Mazouni","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2017.07.001_bib11","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2017.07.001_bib12","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.ejca.2011.06.014","article-title":"Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favorable prognosis for breast cancer patients","volume":"47","author":"Kong","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2017.07.001_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1245\/s10434-014-3948-3","article-title":"Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017","volume":"22","author":"McGuire","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2017.07.001_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0140-6736(91)90475-5","article-title":"Significance of ipsilateral breast tumour recurrence after lumpectomy","volume":"338","author":"Fisher","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2017.07.001_bib15","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/jso.23586","article-title":"A\u00a0nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy","volume":"109","author":"Matsuda","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.clbc.2017.07.001_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/cncr.23130","article-title":"MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy","volume":"112","author":"Chen","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2017.07.001_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12282-010-0235-4","article-title":"MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes","volume":"18","author":"Nakahara","year":"2011","journal-title":"Breast Cancer"},{"key":"10.1016\/j.clbc.2017.07.001_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/ol.2012.1004","article-title":"Analysis of complete response by MRI\u00a0following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer","volume":"5","author":"Hayashi","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clbc.2017.07.001_bib19","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.27995","article-title":"Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017","volume":"119","author":"De Los Santos","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2017.07.001_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40064-016-1800-x","article-title":"Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype","volume":"5","author":"Fukuda","year":"2016","journal-title":"Springerplus"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917301076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917301076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:16:53Z","timestamp":1761513413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820917301076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1526820917301076"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2017.07.001","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}